Fox Run Management’s Epizyme, Inc EPZM Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2019
Q2 | – | Sell |
-11,717
| Closed | -$145K | – | 683 |
|
|
2019
Q1 | $145K | Buy |
+11,717
| New | +$145K | 0.08% | 411 |
|
|
2018
Q3 | – | Sell |
-31,428
| Closed | -$426K | – | 890 |
|
|
2018
Q2 | $426K | Buy |
31,428
+10,337
| +49% | +$140K | 0.14% | 308 |
|
|
2018
Q1 | $374K | Buy |
21,091
+1,816
| +9% | +$32.2K | 0.09% | 421 |
|
|
2017
Q4 | $242K | Buy |
19,275
+7,575
| +65% | +$95.1K | 0.07% | 526 |
|
|
2017
Q3 | $223K | Buy |
+11,700
| New | +$223K | 0.06% | 580 |
|
|
2016
Q2 | – | Sell |
-14,900
| Closed | -$181K | – | 712 |
|
|
2016
Q1 | $181K | Buy |
+14,900
| New | +$181K | 0.12% | 351 |
|